Literature DB >> 8029599

[Primary lymphomas of the large intestine].

A Habr-Gama1, F G Campos, U Ribeiro Júnior, R Gansl, J H da Silva, H W Pinotti.   

Abstract

Primary colorectal lymphomas are rare tumors that comprise 0.5 to 2% of large bowel malignancies and 10 to 20% of gastrointestinal lymphomas. Between 1982-1993 ten patients were treated in the Colorectal Unit of the "Hospital das Clínicas" of the University of São Paulo, representing 2% of the neoplasms in this period. Age varied from 22 to 76 years, with median around 50 years, and male/female ratio 8:2. Weight loss, right iliac palpable mass and bowel habit alterations were the most common symptoms. Definitive diagnostic was only set with histological evaluation of the surgical specimen in all colon tumors. Four patients had advanced disease classified as stages III or IV. The tumors were located in ileocecal region (7 cases), transverse colon (1 case), sigmoid colon (1 case) and rectum (1 case). Colon lymphomas were treated by radical surgical resection and chemotherapy; the patient with rectal lymphoma received radiotherapy and chemotherapy because of local tumor spread. Histological data showed 6 large cell lymphomas and 4 small cleaved cells lymphomas. Lymphnodal involvement and tumor size were the main prognostic factors in the series: 80% of the patients in advanced stage (III or IV) and 66% of those with tumors larger than 10 cm died during the first year of the follow-up.

Entities:  

Mesh:

Year:  1993        PMID: 8029599

Source DB:  PubMed          Journal:  Rev Hosp Clin Fac Med Sao Paulo        ISSN: 0041-8781


  2 in total

1.  An unusual case of fever and a sigmoid mass.

Authors:  Tamara Kubba; Mio Takatsuka; Eve Stern; Thomas Smith; Jason Lee; Maitham Al-Whouhayb; Michael Saunders
Journal:  BMJ Case Rep       Date:  2011-03-29

2.  Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma masquerading as Behcet's disease: A case report and review of literature.

Authors:  Juan Luo; Ying-Han Jiang; Zi Lei; Ying-Lei Miao
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.